New Viswabharathy Drug Lines Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.00 Cr
About New Viswabharathy Drug Lines
New Viswabharathy Drug Lines Private Limited (NVDLPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 May 2022 (Two years and eight months 28 days old ). Its registered office is in Palakkad, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹8.00 Cr.
Narasaiah Arigela, Anish Akbar, and Ahammed Ismail serve as directors at the Company.
Company Details
-
Location
Palakkad, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299KL2022PTC075397
-
Company No.
075397
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 May 2022
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at New Viswabharathy Drug Lines?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anish Akbar
|
Managing Director | 06-May-2022 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Narasaiah Arigela
|
Director | 12-Jul-2024 | Current |
|
Ahammed Ismail
|
Director | 06-May-2022 | Current |
Financial Performance of New Viswabharathy Drug Lines.
New Viswabharathy Drug Lines Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of New Viswabharathy Drug Lines?
Unlock access to New Viswabharathy Drug Lines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Indian Hospitex Private LimitedNarasaiah Arigela is a mutual person
-
Auspharma Private LimitedNarasaiah Arigela is a mutual person
-
Guninaa Pharmaceuticals Private Limited
Narasaiah Arigela is a mutual person
-
Prime Time Logistics Technologies Private Limited
Narasaiah Arigela is a mutual person
-
Adeline Pharmaceuticals Private Limited
Narasaiah Arigela is a mutual person
-
Balaji Trade Pharma Private Limited
Narasaiah Arigela is a mutual person
Charges (Loans)
₹80.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 8.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Aug 2024 | Hdfc Bank Limited | ₹8.00 Cr | Open |
How Many Employees Work at New Viswabharathy Drug Lines?
New Viswabharathy Drug Lines has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New Viswabharathy Drug Lines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Viswabharathy Drug Lines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.